XENT Insider Trading Activity and SEC Form 4 Filings
XENT insider trading summary
No open-market insider purchases or sales of Intersect ENT, Inc. (XENT) have been reported on SEC Form 4 in the past 12 months.
Latest XENT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 17, 2020 | Thomas A. West | President and CEO | Buy | $161K (19,035 @ $8.48) |
| Mar 17, 2020 | Richard A Meier | EVP & Chief Financial Officer | Buy | $39K (5,000 @ $7.80) |
| Mar 16, 2020 | Richard A Meier | EVP & Chief Financial Officer | Buy | $34K (2,500 @ $13.50) |
| Mar 16, 2020 | Richard A Meier | EVP & Chief Financial Officer | Buy | $34K (2,500 @ $13.75) |
| Mar 16, 2020 | Richard A Meier | EVP & Chief Financial Officer | Buy | $25K (2,500 @ $10.19) |
| Mar 16, 2020 | Richard A Meier | EVP & Chief Financial Officer | Buy | $32K (2,500 @ $12.75) |
| Nov 5, 2019 | Robert H Binney Jr | Chief Commercial Officer | Sell | $551K (25,584 @ $21.54) |
| Jun 13, 2019 | Susan P Stimson | Chief Strategy Officer | Sell | $9K (350 @ $25.00) |
| May 15, 2019 | Lisa D Earnhardt | President and CEO | Sell | $243K (9,500 @ $25.59) |
| May 10, 2019 | Susan P Stimson | Chief Strategy Officer | Sell | $146K (5,350 @ $27.38) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.